These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16691192)

  • 1. Both pimecrolimus and corticosteroids deplete plasmacytoid dendritic cells in patients with atopic dermatitis.
    Hoetzenecker W; Meindl S; Stuetz A; Stingl G; Elbe-Bürger A
    J Invest Dermatol; 2006 Sep; 126(9):2141-4. PubMed ID: 16691192
    [No Abstract]   [Full Text] [Related]  

  • 2. Spotlight on topical pimecrolimus in pediatric atopic dermatitis.
    Yang LP; Curran MP
    Am J Clin Dermatol; 2010; 11(4):295-8. PubMed ID: 20509720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids.
    Kirsner RS; Heffernan MP; Antaya R
    Acta Derm Venereol; 2010; 90(1):58-64. PubMed ID: 20107727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pimecrolimus 1% cream for the treatment of atopic dermatitis.
    Wolff K
    Skin Therapy Lett; 2005 Oct; 10(8):1-6. PubMed ID: 16292456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pimecrolimus on innate immunity in subjects with atopic dermatitis: a double-blind, randomized, vehicle-controlled study.
    Afshar M; Kotol P; Miller J; Gallo R; Hata T
    Br J Dermatol; 2013 Feb; 168(2):426-8. PubMed ID: 22577776
    [No Abstract]   [Full Text] [Related]  

  • 7. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How I treat ... atopic dermatitis by topical pimecrolimus (Elidel). The emerging paradigm of calcineurin inhibitors].
    Piérard-Franchimont C; Quatresooz P; Piérard GE
    Rev Med Liege; 2005 Mar; 60(3):136-40. PubMed ID: 15884695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tacrolimus and pimecrolimus ointments in the treatment of atopic eczema].
    Reitamo S; Remitz A
    Duodecim; 2003; 119(9):825-7. PubMed ID: 12815980
    [No Abstract]   [Full Text] [Related]  

  • 10. Pimecrolimus 1% cream for perianal atopic dermatitis.
    Kreuter A; Hochdorfer B; Altmeyer P; Gambichler T
    Br J Dermatol; 2005 Jan; 152(1):186-7. PubMed ID: 15656832
    [No Abstract]   [Full Text] [Related]  

  • 11. Review of pimecrolimus cream 1% in children for the treatment of mild to moderate atopic dermatitis.
    Cohen B
    Clin Pediatr (Phila); 2007 Jan; 46(1):7-15. PubMed ID: 17164503
    [No Abstract]   [Full Text] [Related]  

  • 12. StabiEL: stabilization of skin condition with Elidel--a patients' satisfaction observational study addressing the treatment, with pimecrolimus cream, of atopic dermatitis pretreated with topical corticosteroid.
    Gollnick H; Luger T; Freytag S; Bräutigam M;
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1319-25. PubMed ID: 18540990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    van der Laan JR
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1816; author reply 1817. PubMed ID: 16121669
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical treatment for atopic dermatitis in the 21st century.
    Johnson SM; Kincannon JM; Dudney DL;
    J Ark Med Soc; 2004 Sep; 101(3):86-90. PubMed ID: 15384500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema?
    Wilkes SR; Nankervis H; Tavernier E; Maruani A; Williams HC
    J Invest Dermatol; 2016 Oct; 136(10):1944-1949. PubMed ID: 27265005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of pimecrolimus on the innate immune response in atopic dermatitis.
    Danby SG; Cork MJ
    Br J Dermatol; 2013 Feb; 168(2):235-6. PubMed ID: 23362967
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial.
    Sigurgeirsson B; Boznanski A; Todd G; Vertruyen A; Schuttelaar ML; Zhu X; Schauer U; Qaqundah P; Poulin Y; Kristjansson S; von Berg A; Nieto A; Boguniewicz M; Paller AS; Dakovic R; Ring J; Luger T
    Pediatrics; 2015 Apr; 135(4):597-606. PubMed ID: 25802354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pimecrolimus versus topical corticosteroids in dermatology.
    Korfitis C; Gregoriou S; Rallis E; Rigopoulos D
    Expert Opin Pharmacother; 2007 Jul; 8(10):1565-73. PubMed ID: 17661737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and cytological effects of pimecrolimus cream 1% after resolution of active atopic dermatitis lesions by topical corticosteroids: a randomized controlled trial.
    Bangert C; Strober BE; Cork M; Ortonne JP; Luger T; Bieber T; Ferguson A; Ecker RC; Kopp T; Weise-Riccardi S; Guettner A; Stingl G
    Dermatology; 2011 Feb; 222(1):36-48. PubMed ID: 21150167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
    Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.